(R)-2-[4-(quinolin-2-yl-methoxy)phenyl]-2-cyclopentyl] acetic acid (BAY x1005), a potent leukotriene synthesis inhibitor: effects on anti-IgE challenge in human airways
about
Attenuation of early and late phase allergen-induced bronchoconstriction in asthmatic subjects by a 5-lipoxygenase activating protein antagonist, BAYx 1005Effect of Fluticasone propionate Aqueous Nasal Spray Treatment on Platelet Activating Factor and Eicosanoid Production By nasal Mucosa in Patients with A house Dust Mite AllergyPulmonary hypertension in infants with congenital heart defects: are leukotrienes involved?Inhibition of allergen-induced airway obstruction and leukotriene generation in atopic asthmatic subjects by the leukotriene biosynthesis inhibitor BAYx 1005Anti-IgE Response in Human Airways: Relative Contribution of Inflammatory Mediators.Effects of beta 2-adrenoceptor agonists on anti-IgE-induced contraction and smooth muscle reactivity in human airways
P2860
(R)-2-[4-(quinolin-2-yl-methoxy)phenyl]-2-cyclopentyl] acetic acid (BAY x1005), a potent leukotriene synthesis inhibitor: effects on anti-IgE challenge in human airways
description
im Februar 1994 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 February 1994
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в лютому 1994
@uk
name
(R)-2-[4-(quinolin-2-yl-methox ...... IgE challenge in human airways
@en
(R)-2-[4-(quinolin-2-yl-methox ...... IgE challenge in human airways
@nl
type
label
(R)-2-[4-(quinolin-2-yl-methox ...... IgE challenge in human airways
@en
(R)-2-[4-(quinolin-2-yl-methox ...... IgE challenge in human airways
@nl
prefLabel
(R)-2-[4-(quinolin-2-yl-methox ...... IgE challenge in human airways
@en
(R)-2-[4-(quinolin-2-yl-methox ...... IgE challenge in human airways
@nl
P2093
P1476
(R)-2-[4-(quinolin-2-yl-methox ...... IgE challenge in human airways
@en
P2093
J P Gascard
P J Gardiner
R Müller-Peddinghaus
W A Taylor
P304
P407
P577
1994-02-01T00:00:00Z